Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.

Autor: Jeremiah K; Mwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania., Lyimo E; Mwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania., Ritz C; Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark., PrayGod G; Mwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania., Rutkowski KT; International AIDS Vaccine Initiative (IAVI,), New York City, New York, United States of America., Korsholm KS; Department of Infectious Immunology, Centre for Vaccine Research, Statens Serum Institut (SSI), Copenhagen, Denmark.; Department of Vaccine Development, Centre for Vaccine Research, Statens Serum Institut (SSI), Copenhagen, Denmark., Ruhwald M; Department of Infectious Immunology, Centre for Vaccine Research, Statens Serum Institut (SSI), Copenhagen, Denmark.; Department of Vaccine Development, Centre for Vaccine Research, Statens Serum Institut (SSI), Copenhagen, Denmark.; Foundation of Innovative New Diagnostics, Geneva, Switzerland., Tait D; International AIDS Vaccine Initiative (IAVI) NPC, Cape Town, South Africa., Grewal HMS; Department of Clinical Science, BIDS Group, Faculty of Medicine, University of Bergen, Bergen, Norway.; Department of Microbiology, Haukeland University Hospital, Bergen, Norway., Faurholt-Jepsen D; Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.

Publikováno v: PloS one [PLoS One] 2021 Jun 07; Vol. 16 (6), pp. e0252808. Date of Electronic Publication: 2021 Jun 07 (Print Publication: 2021).

Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.

Autor: Schmidt ST; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark; Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, 2300 Copenhagen S, Denmark., Olsen CL; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark; Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, 2300 Copenhagen S, Denmark., Franzyk H; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 162, 2100 Copenhagen Ø, Denmark., Wørzner K; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark; Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, 2300 Copenhagen S, Denmark., Korsholm KS; Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, 2300 Copenhagen S, Denmark., Rades T; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark., Andersen P; Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, 2300 Copenhagen S, Denmark., Foged C; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen Ø, Denmark., Christensen D; Statens Serum Institut, Department of Infectious Disease Immunology, Artillerivej 5, 2300 Copenhagen S, Denmark. Electronic address: den@ssi.dk.

Publikováno v: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2019 Jul; Vol. 140, pp. 29-39. Date of Electronic Publication: 2019 May 02.

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant.

Autor: Christensen D; Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Copenhagen, Denmark., Christensen JP; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Korsholm KS; Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Copenhagen, Denmark., Isling LK; Department of Quality Assurance/Quality Control, Section of Biological Service, Division of Vaccine, Statens Serum Institut, Copenhagen, Denmark., Erneholm K; Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Copenhagen, Denmark., Thomsen AR; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Andersen P; Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Copenhagen, Denmark.

Publikováno v: Frontiers in immunology [Front Immunol] 2018 Jan 08; Vol. 8, pp. 1928. Date of Electronic Publication: 2018 Jan 08 (Print Publication: 2017).

Adjuvants Based on Synthetic Mycobacterial Cord Factor Analogues: Biophysical Properties of Neat Glycolipids and Nanoself-Assemblies with DDA.

Autor: Kallerup RS; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Jagtvej 162, DK-2100 Copenhagen Ø, Denmark.; Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut , Artillerivej 5, DK-2300 Copenhagen S, Denmark., Franzyk H; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Jagtvej 162, DK-2100 Copenhagen Ø, Denmark., Schiøth ML; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Jagtvej 162, DK-2100 Copenhagen Ø, Denmark., Justesen S; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Jagtvej 162, DK-2100 Copenhagen Ø, Denmark., Martin-Bertelsen B; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark., Rose F; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark., Madsen CM; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark., Christensen D; Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut , Artillerivej 5, DK-2300 Copenhagen S, Denmark., Korsholm KS; Department of Infectious Disease Immunology, Vaccine Adjuvant Research, Statens Serum Institut , Artillerivej 5, DK-2300 Copenhagen S, Denmark., Yaghmur A; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark., Foged C; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark.

Publikováno v: Molecular pharmaceutics [Mol Pharm] 2017 Jul 03; Vol. 14 (7), pp. 2294-2306. Date of Electronic Publication: 2017 May 31.